Clinical Trials Browser

Phase 3 × Neoplasms × Palonosetron × Clear all

NCT03578081 2025-04-06

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

690 enrolled 17 charts

Neoplasms

NCT02203253 2016-08-24

Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting

Phase 3 Completed

Neoplasms, Vomiting